Back
Ares Management Vs. Longboard Pharmaceuticals Industry Stock Comparison
Buy
83
ARES
Ares Management
Last Price:
156.51
Seasonality Move:
-1.63%
Buy
56
LBPH
Longboard Pharmaceuticals
Last Price:
33.39
Seasonality Move:
-17.05%
Buy
83
Ares Management (ARES)
is a Buy
Is Ares Management a Buy, Sell or Hold?
- The current Ares Management [ARES] share price is $156.51. The Score for ARES is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
- ARES is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
56
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $33.44. The Score for LBPH is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ARES Stock Price Chart
What is Ares Management's stock price today?
-
The Ares Management share price today is $156.51
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARES is experiencing slight buying pressure.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $33.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARES Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.33 | Buy |
| Relative Strength Index (14 RSI): | 70.19 | Buy |
| Chaikin Money Flow: | 390938 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (140.94 - 149.4) | Buy |
| Bollinger Bands (100): | (135.72 - 147.04) | Buy |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.89 | Sell |
| Relative Strength Index (14 RSI): | 49.93 | Sell |
| Chaikin Money Flow: | 634470 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.11 - 36.33) | Sell |
| Bollinger Bands (100): | (20.95 - 35.89) | Buy |
ARES Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 147.98 | Buy |
| 20-day SMA: | 145.24 | Buy |
| 50-day SMA: | 144.63 | Buy |
| 200-day SMA: | 133.77 | Buy |
| 8-day EMA: | 149.63 | Buy |
| 20-day EMA: | 146.29 | Buy |
| 50-day EMA: | 143.88 | Buy |
| 200-day EMA: | 132.66 | Buy |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.2 | Buy |
| 20-day SMA: | 33.96 | Sell |
| 50-day SMA: | 34.9 | Sell |
| 200-day SMA: | 23.24 | Buy |
| 8-day EMA: | 31.98 | Buy |
| 20-day EMA: | 33.25 | Buy |
| 50-day EMA: | 32.72 | Buy |
| 200-day EMA: | 24.14 | Buy |
Ares Management Earnings Growth & ARES Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.35 per share, an increase this year of $0.60 per share, and an increase next year of $1.63 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.21 per share, and a decrease next year of $0.53 per share.
Ares Management Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||